Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
58
ATAI Quote, Financials, Valuation and Earnings
Last price:
$3.76
Seasonality move
:
-9.82%
Day range:
$3.44 - $3.80
52-week range:
$1.15 - $6.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
231.10x
P/B ratio:
8.57x
Volume:
4.5M
Avg. volume:
4M
1-year change:
77.83%
Market cap:
$1.4B
Revenue:
$308K
EPS (TTM):
-$0.74
Analysts' Opinion
-
Consensus RatingAtai Beckley, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 11 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $12.27, Atai Beckley, Inc. has an estimated upside of 225.54% from its current price of $3.77.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $7.00 representing 100% downside risk from its current price of $3.77.
Fair Value
-
According to the consensus of 11 analysts, Atai Beckley, Inc. has 225.54% upside to fair value with a price target of $12.27 per share.
ATAI vs. S&P 500
-
Over the past 5 trading days, Atai Beckley, Inc. has overperformed the S&P 500 by 0.36% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Atai Beckley, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Atai Beckley, Inc. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Atai Beckley, Inc. reported revenues of $749K.
Earnings Growth
-
Atai Beckley, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Atai Beckley, Inc. reported earnings per share of -$0.28.
Enterprise value:
1.3B
EV / Invested capital:
--
Price / LTM sales:
231.10x
EV / EBIT:
--
EV / Revenue:
410.65x
PEG ratio (5yr expected):
-0.05x
EV / Free cash flow:
-15.99x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$2.3M
Return On Assets:
-68.21%
Net Income Margin (TTM):
-4623.57%
Return On Equity:
-91.85%
Return On Invested Capital:
-82.97%
Operating Margin:
-3796.53%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $334K | $331K | $3.1M | $40K | $749K | |
| Gross Profit | -$155K | -$18K | $2.3M | -$43K | $516K | |
| Operating Income | -$129.4M | -$105.9M | -$95.6M | -$22.6M | -$28.4M | |
| EBITDA | -$128.9M | -$105.5M | -$94.8M | -$22.5M | -$28.2M | |
| Diluted EPS | -$0.42 | -$0.80 | -$0.74 | -$0.16 | -$0.28 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $441.9M | $317.5M | $215.8M | $114.1M | $130.7M | |
| Total Assets | $484.1M | $342.6M | $308.2M | $197.5M | $239.8M | |
| Current Liabilities | $15.3M | $25.9M | $19.7M | $19.6M | $16.5M | |
| Total Liabilities | $21.3M | $46.5M | $39.7M | $51.2M | $79.9M | |
| Total Equity | $462.8M | $296.1M | $268.5M | $146.3M | $159.9M | |
| Total Debt | $838K | $15M | $16.4M | $23.6M | $2.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$94.3M | -$79.9M | -$77.8M | -$20.1M | -$24.6M | |
| Cash From Investing | $20.1M | $53M | -$46.4M | $25.5M | -$70.7M | |
| Cash From Financing | -$172.5K | -$3.1M | $137.9M | $4.9M | $63M | |
| Free Cash Flow | -$95.1M | -$79.9M | -$78.7M | -$20.1M | -$25M | |
ATAI
Sector
Market Cap
$1.4B
$23.4M
Price % of 52-Week High
55.85%
48.49%
Dividend Yield
0%
0%
Shareholder Yield
-11.39%
-1.67%
1-Year Price Total Return
77.83%
-23.18%
Beta (5-Year)
--
0.504
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$3.75
200-day SMA
Buy
Level
$3.72
Bollinger Bands (100)
Sell
Level
3.77 - 5.33
Chaikin Money Flow
Buy
Level
50.4M
20-day SMA
Sell
Level
$3.79
Relative Strength Index (RSI14)
Sell
Level
47.20
ADX Line
Sell
Level
11.36
Williams %R
Neutral
Level
-47.0526
50-day SMA
Sell
Level
$3.96
MACD (12, 26)
Sell
Level
-0.09
25-day Aroon Oscillator
Sell
Level
-92
On Balance Volume
Neutral
Level
133.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-4.73)
Sell
CA Score
(Annual)
Level (-1.1632)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (7.0887)
Sell
Piotroski F Score
(Annual)
Level (3)
Sell
Quality Ratio Score
Level (3)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.
Stock Forecast FAQ
In the current month, ATAI has received 11 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ATAI average analyst price target in the past 3 months is $12.27.
-
Where Will Atai Beckley, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Atai Beckley, Inc. share price will rise to $12.27 per share over the next 12 months.
-
What Do Analysts Say About Atai Beckley, Inc.?
Analysts are divided on their view about Atai Beckley, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Atai Beckley, Inc. is a Sell and believe this share price will drop from its current level to $7.00.
-
What Is Atai Beckley, Inc.'s Price Target?
The price target for Atai Beckley, Inc. over the next 1-year time period is forecast to be $12.27 according to 11 Wall Street analysts, 11 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ATAI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Atai Beckley, Inc. is a Buy. 11 of 11 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ATAI?
You can purchase shares of Atai Beckley, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Atai Beckley, Inc. shares.
-
What Is The Atai Beckley, Inc. Share Price Today?
Atai Beckley, Inc. was last trading at $3.76 per share. This represents the most recent stock quote for Atai Beckley, Inc.. Yesterday, Atai Beckley, Inc. closed at $3.77 per share.
-
How To Buy Atai Beckley, Inc. Stock Online?
In order to purchase Atai Beckley, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get ATAI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ATAI
Sector
P/E ratio
--
23.40x
PEG ratio
-0.05x
-0.01x
P/B ratio
8.57x
1.74x
Price / LTM sales
231.10x
1.48x
Growth Metrics
ATAI
Sector
Revenue growth
174.36%
3.36%
Earnings growth
21.44%
9.35%
Revenue (5-year growth)
--
6.22%
Earnings forecast
-$0.14
-$0.19
Profitability
ATAI
Sector
Profitability FY 2024
-$165K
$2.7M
Return on invested capital
-82.97%
-33.62%
Return on assets
-68.21%
-29.68%
Return on equity
-91.85%
-38.98%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Mar
16
Estimated Next Earnings Date
Feb
11
Balance Sheet
ATAI
Sector
Total cash
$114.6M
$25M
Short term investments
$44.8M
$23.9M
Total assets
$159.4M
$72.5M
Long term debt
$2.4M
$2.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Sell
40
BILL alert for Feb 7
Bill Holdings, Inc. [BILL] is up 37.11% over the past day.
Buy
75
PRLB alert for Feb 7
Proto Labs, Inc. [PRLB] is up 28.33% over the past day.
Sell
30
MSTR alert for Feb 7
Strategy, Inc. [MSTR] is up 26.08% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
